v3.24.1
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)
12 Months Ended
Dec. 31, 2023
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities  
Schedule of marketable investment securities, restricted cash and cash equivalents, and other investment securities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31,

​

​

 

2023

    

2022

 

​

​

(In thousands)

​

Marketable investment securities:

​

​

​

​

​

​

​

Current marketable investment securities

​

$

397

​

$

282,733

​

​

​

​

​

​

​

​

​

Restricted cash and cash equivalents (1)

​

​

54,980

​

​

53,525

​

​

​

​

​

​

​

​

​

Other investment securities, net:

​

​

​

​

​

​

​

Equity method investments

​

​

90,168

​

​

93,806

​

Total marketable investment securities, restricted cash and cash equivalents, and other investment securities

​

$

145,545

​

$

430,064

​

​

​

​

​

​

​

​

​

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Consolidated Balance Sheets.
Schedule of investments measured at fair value on a recurring basis

Our investments measured at fair value on a recurring basis were as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of December 31,

​

​

​

2023

​

2022

​

​

 

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

​

​

​

(In thousands)

​

Cash equivalents (including restricted)

​

$

411,571

​

$

358,545

​

$

53,026

​

$

—

​

$

650,523

​

$

99,437

​

$

551,086

​

$

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Debt securities (including restricted):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

U.S. Treasury and agency securities

​

$

—

​

$

—

​

$

—

​

$

—

​

$

7,727

​

$

7,727

​

$

—

​

$

—

​

Commercial paper

​

​

—

​

​

—

​

​

—

​

​

—

​

​

227,787

​

​

—

​

​

227,787

​

​

—

​

Corporate securities

​

​

—

​

​

—

​

​

—

​

​

—

​

​

46,764

​

​

—

​

​

46,764

​

​

—

​

Other

​

​

397

​

​

—

​

​

397

​

​

—

​

​

455

​

​

—

​

​

455

​

​

—

​

Total

​

$

397

​

$

—

​

$

397

​

$

—

​

$

282,733

​

$

7,727

​

$

275,006

​

$

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Schedule of Gains and Losses on Sales and Changes in Carrying Amounts of Investments and Other

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31,

​

Other, net:

    

2023

    

2022

    

2021

 

 

​

(In thousands)

​

Gains (losses) related to early redemption of debt

​

$

1,262

​

$

(922)

​

$

(3,587)

​

Equity in earnings (losses) of affiliates

​

​

(1,202)

​

​

4,112

​

​

2,520

​

Other

​

​

458

​

​

1,276

​

​

247

​

Total

​

$

518

​

$

4,466

​

$

(820)

​

​

​

​

​

​

​

​

​

​

​

​

​